beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1) (Middle Region) Peptide
B4GALNT1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all B4GALNT1 products
- B4GALNT1 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- GLGSLRVGSC SDVVVDHASK LKLPWTSRDA GAETYARYRY PGSLDESQMA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-B4GALNT1 Antibody(ARP45118_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- B4GALNT1 (beta-1,4-N-Acetyl-Galactosaminyl Transferase 1 (B4GALNT1))
- Background
-
GM2 and GD2 gangliosides are sialic acid-containing glycosphingolipids. GalNAc-T is the enzyme involved in the biosynthesis of G(M2) and G(D2) glycosphingolipids. B4GALNT1(GalNAc-T) catalyzes the transfer of GalNAc into G(M3) and G(D3) by a beta-1,4 linkage, resulting in the synthesis of G(M2) and G(D2), respectively.
Alias Symbols: GALGT, GALNACT
Protein Interaction Partner: B4GALNT1,B4GALNT1
Protein Size: 533 - Molecular Weight
- 59 kDa
- Gene ID
- 2583
- NCBI Accession
- NM_001478, NP_001469
- UniProt
- Q00973
-
You are here:
